Relationship between serum levels of high motility protein B1, ubiquitin carboxy-terminal hydrolase L1 and poor prognosis of neurological function after cardiopulmonary resuscitation
1.Department of Critical Medicine, the First Affiliated Hospital of Hainan Medical University, Hainan Province, Haikou 570100, China; 2.Emergency Intensive Care Unit, the First Affiliated Hospital of Hainan Medical University, Hainan Province, Haikou 570100, China
Abstract：Objective To investigate the relationship between serum high motility protein B1 (HMGB1), ubiquitin carboxy-terminal hydrolase L1(UCH-L1) and poor prognosis of neurological function after cardiopulmonary resuscitation. Methods A total of 175 patients with spontaneous circulation recovery after cardiopulmonary resuscitation after cardiac arrest admitted to the First Affiliated Hospital of Hainan Medical College from January 2019 to October 2022 were selected as the study objects. The patients were divided into poor prognosis group (75 cases) and good prognosis group (100 cases). Serum HMGB1 and UCH-L1 levels and clinical data （gender, age, body mass index, mechanical ventilation time, smoking history, drinking history, history of previous underlying diseases, cause of cardiac arrest, recovery time of autonomic circulation, pre-hospital emergency time, kidney replacement therapy, Glasgow coma scale (GCS) score, acute physiology and chronic health Ⅱ [APACHEⅡ] score） were compared between the two groups. Multivariate logistic regression was used to analyze the factors affecting the prognosis of neurological function, and receiver operating characteristic (ROC) curve was used to analyze the predictive value of serum HMGB1 and UCH-L1 for poor prognosis of neurological function. Results APACHE Ⅱ score, mechanical ventilation time, and serum HMGB1 and UCH-L1 in the poor prognosis group were higher than those in the good prognosis group, while GCS score was lower than that in the good prognosis group, with statistical significances (P＜0.05). Logistic multivariate regression analysis showed that HMGB1, UCH-L1, and APACHEⅡ scores were independent risk factors for poor prognosis of neurological function after cardiopulmonary resuscitation (OR＞1, P＜0.05). ROC curve analysis showed that HMGB1 combined with UCH-L1 was more effective in predicting poor neurological outcomes than HMGB1 and UCH-L1 alone (P＜0.05). Conclusion Serum HMGB1 and UCH-L1 levels are significantly increased in patients with poor neurological prognosis after cardiopulmonary resuscitation, which are independent risk factors for poor neurological prognosis. Combined detection is helpful for early assessment of poor neurological prognosis in patients.
[1] Wong CX，Brown A，Lau DH，et al. Epidemiology of sudden cardiac death： global and regional perspectives [J]. Heart Lung Circ，2019，28（1）：6-14. [2] Wang H，Tang L，Zhang L，et al. Development a clinical prediction model of the neurological outcome for patients with coma and survived 24 hours after cardiopulmonary resuscitation [J]. Clin Cardiol，2020，43（9）：1024-1031. [3] 卢安阳，吕汝琦.NLR-PLR评分与心搏骤停患者心肺复苏后神经功能预后的关系分析[J].中国分子心脏病学杂志，2023，23（1）：5189-5194. [4] 金自慧，杨大英.血清可溶性生长刺激表达基因2蛋白和高迁移率族蛋白B1对老年急性心力衰竭患者预后的评估价值[J].中国医药，2021，16（3）：326-330. [5] Shahim P，Politis A，van der Merwe A，et al. Time course and diagnostic utility of NfL，tau，GFAP，and UCH-L1 in subacute and chronic TBI [J]. Neurology，2020，95（6）：e623-e636. [6] Sternbach GL. The Glasgow coma scale [J]. J Emerg Med，2000，19（1）：67-71. [7] Knaus WA，Draper EA，Wagner DP，et al. APACHE Ⅱ：a severity of disease classification system [J]. Crit Care Med，1985，13（10）：818-829. [8] Sandroni C，Cariou A，Cavallaro F，et al. Prognostication in comatose survivors of cardiac arrest： an advisory statement from the European Resuscitation Council and the European Society of Intensive Care Medicine [J]. Resuscitation，2014， 85（12）：1779-1789. [9] 蔡振华，王磊，曹继飞.APACHE Ⅱ联合SOFA评分对肺炎克雷伯菌致脓毒症预后的评估价值[J].宁夏医科大学学报，2022，44（11）：1111-1115. [10] 王力，马莉，贾丽君，等.高迁移率族蛋白B1抑制剂对白蛋白结合型紫杉醇致神经病理性疼痛的抑制作用及其机制[J].山西医科大学学报，2022，53（9）：1120-1126. [11] Dong LY，Chen F，Xu M，et al. Quercetin attenuates myocardial ischemia-reperfusion injury via downregulation of the HMGB1-TLR4-NF-κB signaling pathway [J]. Am J Transl Res，2018，10（5）：1273-1283. [12] 魏星，马莉，李维妙，等.HMGB1/TLR4通路在白蛋白结合型紫杉醇致神经病理性疼痛大鼠脊髓的表达[J].山西医科大学学报，2022，53（9）：1113-1119. [13] 乔俊，徐征，史晓静，等.脑外伤术后颅内感染患者血清神经生化标记物及脑脊液中HMGB-1表达意义[J].实验与检验医学，2021，39（6）：1440-1443. [14] 张瑞英，贾焯文，赵发利，等.血清高迁移率族蛋白B1和可溶性晚期糖基化终产物受体与心力衰竭严重程度相关性研究[J].中国循证心血管医学杂志，2020，12（3）：320-323. [15] 张列，苗树船，杨中鑫，等.HMGB1下调的作用：通过抑制神经元细胞自噬和凋亡减轻大鼠脑出血后的神经元损伤[J].南方医科大学学报，2022，42（7）：1050-1056. [16] 王华杰，苏醒，麦叶，等.HMGB1抑制剂预处理对大鼠心肺复苏后脑缺血再灌注损伤及TLR4/NF-κB信号通路的影响[J].中国神经免疫学和神经病学杂志，2022， 29（2）：130-134. [17] Yang H，Andersson U，Brines M. Neurons Are a Primary Driver of Inflammation via Release of HMGB1 [J]. Cells，2021，10（10）：2791. [18] 谭家余，黄湘，钟苑芳.可溶性髓系细胞触发受体-1在呼吸机相关性肺炎早期诊断中的价值[J].国际检验医学杂志，2020，41（16）：1962-1965，1969. [19] 李星，胡风云，张鹏，等.重症缺血性脑卒中病人血清泛素羧基末端水解酶1的变化趋势及其临床意义[J].中西医结合心脑血管病杂志，2019，17（9）：1392-1395. [20] 张园园，谭忠兵，管义祥.血清UCH-L1水平与急性脑梗死的诊断及预后关系探讨[J].中国实验诊断学，2022， 26（6）：864-868. [21] 白高伟，束新辉，刘洎，等.血清sTREM-1、UCH-L1对重度脑损伤患者预后的评估价值[J].河南医学研究，2021，30（36）：6745-6748. [22] Ramezani F，Bahrami-Amiri A，Babahajian A，et al. Ubiquitin C-Terminal Hydrolase-L1 （UCH-L1） in Prediction of Computed Tomography Findings in Traumatic Brain Injury; a Meta-Analysis [J]. Emerg （Tehran），2018，6（1）：e62. [23] Zhang M，Chen MY，Wang SL，et al. Association of Ubiquitin C-Terminal Hydrolase-L1 （Uch-L1） serum levels with cognition and brain energy metabolism [J]. Eur Rev Med Pharmacol Sci，2022，26（10）：3656-3663. [24] 徐慈，李亚茜，项涛.血清泛素羧基末端水解酶1、脑红蛋白与心肺复苏后昏迷患者神经功能预后的关系研究[J].中国综合临床，2021，37（5）：431-437. [25] 李妍平，李斌，董小林，等.急性脑梗死患者应用机械取栓联合尿激酶动脉溶栓治疗的疗效及对神经功能的影响[J].中国医药科学，2022，12（3）：15-19. [26] 李乃妍，宋莉，孙嫚丽，等.职业性一氧化碳中毒患者相关血液标志物的动态研究[J].工业卫生与职业病，2022， 48（5）：349-354. [27] 崔博.参七脑康胶囊联合神经节苷脂钠注射液治疗急性颅脑损伤患者的临床效果及对神经细胞因子、suPAR、IGF-Ⅱ、UCH-L1水平的影响[J].中国医学创新，2023， 20（9）：36-40.
2023, Vol. 20 
京公网安备 11010502046598号